This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levine, M. A. Articles by Leenen, F. H. Search for Related Content PubMed PubMed Citation Articles by Levine, M. A. Articles by Leenen, F. H.

Circulation, Vol 79, 107-115, Copyright © 1989 by American Heart Association

ARTICLES

Role of beta 1-receptors and vagal tone in cardiac inotropic and chronotropic responses to a beta 2-agonist in humans

MA Levine and FH Leenen
Division of Clinical Pharmacology, Toronto Western Hospital, Ontario, Canada.

To assess the contribution of cardiac beta 2-receptors in the cardiac inotropic and chronotropic responses to a beta 2 agonist, terbutaline was infused (0.2 and 0.4 micrograms/kg/min), alone or after pretreatment with either oral atenolol 50 mg or atropine 0.04 mg/kg i.v. or both in six healthy subjects with a multiple crossover design. Terbutaline 0.2 micrograms/kg/min increased heart rate by 15 +/- 2 beats/min, and this response doubled (to 29 +/- 3 beats/min) when the terbutaline infusion followed atropine pretreatment, whereas atenolol pretreatment had no significant effect. Heart rate increased by 44 +/- 2 beats/min in response to terbutaline 0.4 micrograms/kg/min. This response was not affected by atropine. Pretreatment with atenolol diminished the chronotropic response to the higher dose of terbutaline to 27 +/- 4 beats/min. The inotropic response (i.e., changes in pressure: volume ratio) to terbutaline 0.2 micrograms/kg/min was potentiated by atropine (from 1.6 +/- 0.3 to 3.4 +/- 0.8 mm Hg/ml), whereas atenolol pretreatment had no effect. At the higher dose of terbutaline, atropine pretreatment had no additional effect, whereas atenolol decreased the rise in pressure: volume ratio from 6.0 +/- 1.4 to 2.6 +/- 1.0 mm Hg/ml. The results with atenolol pretreatment indicate that cardiac beta 1 responses are associated with the higher dose of terbutaline, either through direct beta 1 stimulation or indirectly from presynaptic beta 2 activity. The atropine data show that vagal tone actually increased during the terbutaline infusions, blunting the cardiac effects. The results of the present study support the existence of functional chronotropic, as well as inotropic, beta 2 receptors in the healthy human heart.

This article has been cited by other articles:

				C. Battram, S. J. Charlton, B. Cuenoud, M. R. Dowling, R. A. Fairhurst, D. Farr, J. R. Fozard, J. R. Leighton-Davies, C. A. Lewis, L. McEvoy, et al. In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (Indacaterol), a Novel Inhaled beta2 Adrenoceptor Agonist with a 24-h Duration of Action J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 762 - 770. [Abstract] [Full Text] [PDF]

				W. W. Waters, S. H. Platts, B. M. Mitchell, P. A. Whitson, and J. V. Meck Plasma volume restoration with salt tablets and water after bed rest prevents orthostatic hypotension and changes in supine hemodynamic and endocrine variables Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H839 - H847. [Abstract] [Full Text] [PDF]

				J. C Coons, M. Shullo, K. Schonder, and R. Kormos Terbutaline for Chronotropic Support in Heart Transplantation Ann. Pharmacother., April 1, 2004; 38(4): 586 - 589. [Abstract] [Full Text] [PDF]

				O.-E. Brodde and M. C. Michel Adrenergic and Muscarinic Receptors in the Human Heart Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690. [Abstract] [Full Text] [PDF]

				G. E. Newton, E. R. Azevedo, and J. D. Parker Inotropic and Sympathetic Responses to the Intracoronary Infusion of a ß2-Receptor Agonist : A Human In Vivo Study Circulation, May 11, 1999; 99(18): 2402 - 2407. [Abstract] [Full Text] [PDF]

				U. Poller, B. Fuchs, A. Gorf, J. Jakubetz, J. Radke, K. Ponicke, and O.-E. Brodde Terbutaline-induced desensitization of human cardiac {beta}2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen Cardiovasc Res, October 1, 1998; 40(1): 211 - 222. [Abstract] [Full Text] [PDF]

				F. H.H. Leenen, R. A. Davies, and A. Fourney Role of Cardiac ß2-Receptors in Cardiac Responses to Exercise in Cardiac Transplant Patients Circulation, February 1, 1995; 91(3): 685 - 690. [Abstract] [Full Text]